<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <link href="https://fonts.googleapis.com/css2?family=Titillium+Web:wght@400;600&display=swap" rel="stylesheet">
    <title>News - Ora Biomedical, Inc.</title>
    <link rel="stylesheet" href="css/styles.css">
</head>
<body>

    <header>
        <img id="OraLogo_Home" src="images/OraBiomedical.png" alt="Ora Biomedical">
        <nav>
            <ul>
                <li><a href=" "> </a></li>
                <li><a href=" "> </a></li>
                <li><a href=" "> </a></li>
                <li><a href=" "> </a></li>
                <li><a href="news.html">News</a></li>
                <li><a href="science.html">Science</a></li>
                <li><a href="company.html">Company</a></li>
                <li><a href="MMC.html">Million Molecule Challenge</a></li>
                <li><a href="contact.html">Contact</a></li>
                <li><a href="shoppingcart.html">Shopping Cart</a></li>
            </ul>
        </nav>
    </header>

    <div>

        <main>
            <h1>Company and Research News</h1>
            <h2>The latest news from Ora Biomedical, longevity biotechnology, 
                and geroscience breakthroughs.</h2>
        </main>

        <div class="section">
            <div class="wave-container">
                <canvas class="wave-canvas"></canvas>
                <div class="wave-content">
                    <h2>Ora Biomedical awarded NIH Small Business Innovation Research 
                        Technology Development Grant</h2>

                    <h3><em>September 2, 2024</em></h3>
                    <p>Ora Biomedical announced that it has been selected for a
                            Small Business Innovation Research (SBIR) Phase I grant
                            from the National Institutes of Health (NIH). The Technology Development Grant awarded through the 
                            National Institute on General Medical Sciences (NIGMS) will support 
                            development of EleGantry, an innovative software and hardware 
                            infrastructure designed to enhance rigor and reproducibility in 
                            invertebrate research, with a particular focus on longevity studies 
                            using Caenorhabditis elegans (C. elegans). 
                    </p>
                    <p>Read the article
                        <a href="https://orabiomedical.com/wp-content/uploads
                        /2024/09/ElegantrySBIR_PressRelease.pdf">here.</a>
                    </p>

                    <img src="images/news2.png" alt="news2" style="width:300px">

                </div>
            </div>
        </div>

        <div class="section">
            <div class="wave-container">
                <canvas class="wave-canvas"></canvas>
                <div class="wave-content">
                    <h1>Ora Biomedical partners with the U.S. Air Force to develop 
                        protective space radiation therapeutics based on longevity 
                        science</h1>

                    <div id="right">
                        <img src="images/news3.png" alt="news3" style="width:300px">
                    </div>

                    <div id="left">
                        <h3><em>May 28, 2024</em></h3>
                        <p>Ora Biomedical has been selected by AFWERX, the 
                            innovation arm of the Department of the Air Force 
                            powered by the Air Force Research Laboratory (AFRL), 
                            for a Phase I SBIR grant to develop novel therapeutics 
                            to protect astronauts and high-altitude pilots from 
                            elevated space radiation based on its work identifying 
                            and developing age-targeting longevity interventions. 
                        </p>
                        <p>Read the article <a href="https://orabiomedical.com/
                            wp-content/uploads/2024/05/SBIR-Phase-I-Press-Release.pdf">here</a>.</p>
                    </div>
                </div>
            </div>
        </div>

        <div class="section">
            <div class="wave-container">
                <canvas class="wave-canvas"></canvas>
                <div class="wave-content">
                    <h2>Ora Biomedical partners with Lifespan.io to fiscally 
                        sponsor the Million Molecule Challenge</h2>

                    <p>Lifespan.io is a leading nonprofit advocacy foundation 
                        and online platform committed to advancing the science
                        of aging and promoting healthy human lifespan. By 
                        supporting groundbreaking research projects, 
                        disseminating educational resources, and raising public 
                        awareness about the importance of longevity, 
                        Lifespan.io aims to accelerate the development of 
                        therapies that can improve the quality of life for                             people worldwide. With a focus on collaboration and 
                        innovation, Lifespan.io is driving the conversation 
                        on aging research and transforming the way we approach 
                        health and wellness throughout our lives. For more 
                        information, please visit 
                        <a href="https://www.lifespan.io/">Lifespan.io.</a>
                    </p>

                    <img src="images/news4.png" alt="news4" style="width:450px">

                </div>
            </div>
        </div>

        <div class="section">
            <div class="wave-container">
                <canvas class="wave-canvas"></canvas>
                <div class="wave-content">
                    <h1>Ora Biomedical announces Optispan Ventures as Lead Investor
                        in Pre-Seed Financing</h1>

                        <h3><em>August 29, 2022</em></h3>
                        <p>Seattle, WA – Ora Biomedical, Inc., is proud to announce
                            an investment deal with Optispan Ventures that 
                            includes financing and research headquarters to build 
                            a high-throughput longevity drug discovery facility in 
                            the Pacific Northwest. Optispan Ventures is focused on
                            healthspan innovations that will define 21st Century 
                            Medicine. “Interventions that target the biology of 
                            aging have the potential to dramatically improve 
                            quality of life by increasing healthspan – a healthy, 
                            disease-free lifespan is the goal. We are pleased to 
                            partner with Ora to apply their game-changing 
                            Wormbot-AI technology and go far beyond what has 
                            previously been possible in this field”, says Stuart 
                            McKee, CEO of Optispan.Optispan Ventures and Ora 
                            Biomedical have a shared vision of revolutionizing 
                            how we age” says Ora Biomedical CEO, Dr. Mitchell 
                            Lee. “Thanks to our partnership with Optispan, we can
                            accelerate the launch of our longevity drug 
                            discovery factory and move one step closer to 
                            developing breakthrough healthy aging therapeutics 
                            for humans and all other animals we love.” For more 
                            information, see full 
                            <a href="https://orabiomedical.com/wp-content/uploads/
                            2022/08/PRESS-RELEASE_Ora-Optispan_08292022-1.pdf">Press Release</a>
                        </p>

                        <img src="images/news5.png" alt="news5" style="width:450px">
                </div>
            </div>
        </div>
            
    </div>

    <img id="OraLogo" src="images/OraLogo_Transparency.png" style="width:8%" alt="Ora Logo">

    <footer>
        <ul>
            <li>
                <a href="https://x.com/OraBiomedical" class="social-icon" target="_blank" rel="noopener noreferrer" aria-label="X">
                    <svg width="32" height="32" fill="currentColor" viewBox="0 0 1200 1227" xmlns="http://www.w3.org/2000/svg">
                        <path d="M715.6 560.2L1179.4 0H1071.1L663.2 500.5L328.9 0H0L492.3 709.5L0 1227H108.9L542.1 686.1L891.1 1227H1200L715.6 560.2ZM588.4 618.3L551.6 564.4L161.4 91.7H292.1L613.4 536.2L650.2 590.1L1046.4 1135.2H915.5L588.4 618.3Z"/>
                    </svg>
                </a>

            </li>

            <li>
                <a href="https://www.linkedin.com/company/ora-biomedical-inc" class="social-icon" target="_blank" rel="noopener noreferrer" aria-label="LinkedIn">
                <svg width="32" height="32" fill="currentColor" viewBox="0 0 24 24">
                    <path d="M16 8a6 6 0 0 1 6 6v7h-4v-7a2 2 0 0 0-4 0v7h-4v-7a6 6 0 0 1 6-6zM2 9h4v12H2z"/>
                    <circle cx="4" cy="4" r="2"/>
                </svg>
                </a>
            </li>
        </ul>

        <p>&copy; 2025 Ora Biomedical. All rights reserved. Web Design by <a href="https://github.com/florianaewing">Florian Ewing</a></p>
    </footer>

    <script src="js/scripts.js"></script>

</body>
</html>
